Overview
BBIO market data
Price History
BBIO price chart · 1M
- O
- 74.89
- H
- 75.24
- L
- 74.15
- C
- 74.86
- Vol
- 102,821.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $74.89
- Previous Close
- $75.39
- Day High
- $75.24
- Day Low
- $74.15
- 52 Week High
- $93.18
- 52 Week Low
- $62.54
- 7 Day Return
- -2.29%
- 30 Day Return
- -8.66%
- 90 Day Return
- +11.07%
- 1 Year Return
- +15.63%
- Daily Notional Volume
- $7.7M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.79 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.96 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -97.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $48.78 – $93.42 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $14.8B · P/B 150.71 · P/S 20.70.
Company News
10 captured
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing AssetZacks Investment Research ·
BridgeBio Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for AmericansGlobenewswire Inc ·
8-K filing — BridgeBio Pharma, Inc. (BBIO)SEC EDGAR ·